Benjamin Mou
Overview
Explore the profile of Benjamin Mou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baker S, Baker S, Leclerc C, Leclerc C, Atmanspacher-Wirth H, Atmanspacher-Wirth H, et al.
Int J Radiat Oncol Biol Phys
. 2025 Feb;
PMID: 39923903
Purpose/objectives: There are limited data on outcomes in patients with ultracentral pulmonary oligometastases treated with SABR. The purpose of this study was to determine whether ultracentral location was prognostic for...
2.
Wright E, Becker N, Mou B, Hyde D
Cureus
. 2024 Dec;
16(11):e73124.
PMID: 39650945
Linac-based stereotactic radiosurgery (SRS) with planning target volume (PTV) margins <1 mm has become increasingly common in recent years. Optical surface imaging for surface-guided radiation therapy (SGRT) is often used...
3.
Mou B, Hyde D, Becker N
Cureus
. 2024 Oct;
16(9):e69937.
PMID: 39439627
A 74-year-old woman with pathologic T4a N1 M0 adenocarcinoma of the cecum, initially treated with right hemicolectomy, developed rising serum carcinoembryonic antigen levels while receiving adjuvant chemotherapy. Re-staging investigations demonstrated...
4.
Abrina J, Baker S, Cruz-Lim E, Chng N, Ye A, Rathod S, et al.
Pract Radiat Oncol
. 2024 Sep;
PMID: 39303778
Purpose: The optimal SABR treatment delivery schedule in stage I non-small cell lung cancer (NSCLC) remains unclear. This population-based study investigated grade ≥2 toxicity rates, local failure (LF), and overall...
5.
Kunkyab T, Magliari A, Jirasek A, Mou B, Hyde D
J Appl Clin Med Phys
. 2024 Aug;
25(11):e14489.
PMID: 39186819
Purpose: To evaluate the feasibility of an open-source, semi-automated, and reproducible vertex placement tool to improve the efficiency of lattice radiotherapy (LRT) planning. We used polymer gel dosimetry with a...
6.
Schellenberg D, Gabos Z, Duimering A, Debenham B, Fairchild A, Huang F, et al.
Int J Radiat Oncol Biol Phys
. 2024 Aug;
121(1):28-38.
PMID: 39168356
Purpose: This trial examined if patients with ≤5 sites of oligoprogression benefit from the addition of SABR to standard of care (SOC) systemic therapy. Methods And Materials: We enrolled patients...
7.
Olson R, Abraham H, Leclerc C, Benny A, Baker S, Matthews Q, et al.
BMC Cancer
. 2024 Feb;
24(1):171.
PMID: 38310262
Background: Radiotherapy delivery regimens can vary between a single fraction (SF) and multiple fractions (MF) given daily for up to several weeks depending on the location of the cancer or...
8.
Cereno R, Bartlett Q, Lamey M, Hyde D, Mou B
J Radiosurg SBRT
. 2023 Jul;
8(4):313-319.
PMID: 37416334
Stereotactic body radiotherapy (SBRT) planning target volume (PTV) margins are influenced by multiple factors. Data is limited on intrafraction motion in bone SBRT, particularly non-spine lesions. We analyzed intrafraction motion...
9.
Cruz-Lim E, Cereno R, Canal J, Vega Jr G, Inocencio E, Mou B
Int J Radiat Oncol Biol Phys
. 2023 May;
116(2):430-438.
PMID: 37179092
No abstract available.
10.
Kunkyab T, Mou B, Jirasek A, Haston C, Andrews J, Thomas S, et al.
Phys Med Biol
. 2023 May;
68(16).
PMID: 37164024
. The development of radiation-induced fibrosis after stereotactic ablative radiotherapy (SABR) can obscure follow-up images and delay detection of a local recurrence in early-stage lung cancer patients. The objective of...